Spore.Bio

France
Plumergat, Brittany, France

Company profile

Spore.Bio company profile

Spore.Bio develops technology for rapid microbiology testing that uses light-based sensing and AI to detect and quantify microbial contamination in products across industries like food, beverages, cosmetics, pharmaceuticals, and water systems. The company’s platform combines machine learning models with photonic data to produce near-real-time insights about bacterial presence without the long incubation times required by traditional lab methods. Spore.Bio also integrates testing hardware with analytical dashboards that help quality teams monitor contamination trends and process data. The firm collaborates with scientific partners to expand its microbial datasets and continuously refine detection models. Its offerings aim to support manufacturers in transitioning from delayed lab testing toward faster contamination awareness and response.

Business identity

Operating status
Active
Company type
For Profit
Employee range
101-250 employees
Founded
2023-01-01, Month

Headquarters

Country code
FR
Continent
Europe

Capital profile

Funding and company signals

Funding stage
Early Stage Venture
Funding rounds
4
Total equity funding
$31.6M
Last funding
Grant / 2026-01-08
Last equity funding
Series A / $23M
Investors
18
Lead investors
3
Founders
3
Articles
14

Founders and investors

Founders

Amine RajiMaxime MistrettaMohamed Tazi

Lead investors

Google.orgLocalGlobeSingular

Investors

Google.orgLocalGlobePlug and PlayPoint72 VenturesSingular